ArticleScientific reports2021

Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass.

Mark Borris D Aldonza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.